Overview

A Trial to Evaluate the Efficacy and Safety of PMF104 Compared to a Conventional PEG-electrolyte Solution in Children

Status:
Unknown status

Trial end date:
2020-07-01

Target enrollment:

Participant gender:

Summary

A randomised, single-blind, active controlled, multi-centre trial to evaluate the efficacy, safety, tolerability, acceptability and palatability of PMF104 compared to a conventional PEG-electrolyte solution in paediatric subjects requiring a diagnostic procedure concerning the colon.

Phase:

Phase 3

Details

Lead Sponsor:

Alfasigma S.p.A.

Treatments:

Pharmaceutical Solutions